NCT06888336

Brief Summary

This randomized feasibility study is designed to investigate the feasibility of recruitment and delivery of two variations (brief; full) of a virtual Integrative Restoration (iRest) yoga nidra meditation intervention in stressor- or trauma-exposed participants with insomnia and posttraumatic stress symptoms, compared to a waitlist control group. Feasibility will also be examined for data collection (daily sleep diaries and PTSD symptom surveys) and at-home polysomnography (PSG) study completion prior to and following the intervention. Feasibility measures will include study retention and-for the two yoga nidra groups-adherence to study protocol, and acceptability of the intervention will be assessed qualitatively, in semi-structured interviews, and quantitatively, with the Client Satisfaction Questionnaire, following the intervention. Acceptability of the daily surveys will also be assessed quantitatively. Preliminary efficacy of the interventions on the primary treatment outcomes of insomnia and PTSD symptoms and symptom clusters will be assessed. Secondary outcomes include changes in specific sleep architecture assessed in an at-home polysomnogram (sleep stages, including stage N3 percentage, sleep spindles, rapid eye movement (REM) theta, total sleep time, wake after sleep onset time, sleep onset latency, sleep efficiency), daily sleep characteristics (total sleep time, sleep onset latency, wake after sleep onset time, sleep quality), daily PTSD symptoms, and mindfulness. Exploratory outcomes include sleep quality, experiential avoidance, emotion regulation, self-compassion, depression, anxiety, and nightmares.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 21, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2026

Completed
Last Updated

May 4, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

March 6, 2025

Last Update Submit

May 1, 2026

Conditions

Keywords

randomized controlled trialmeditationPTSDinsomnia

Outcome Measures

Primary Outcomes (2)

  • Feasibility: Participant Retention

    Retention will be quantified as percentage of participants that complete different levels of the acute protocol (i.e. ≤25%, 26-50%, 51-75%, \> 75% of daily questionnaires, and second at-home PSG) and percentage that complete the follow-up questionnaires.

    From baseline to follow-up (Weeks 1-10, Week 10, Week 18)

  • Feasibility: Adherence to Yoga Nidra Protocol

    Adherence will be quantified as percentage of participants that complete 1-7 sessions in each week. Also, a measure of 'quality of meditation' (assessed using the PQ-M for each reported meditation) will serve as an additional measure of adherence.

    Throughout treatment (Week 2 to 10)

Secondary Outcomes (8)

  • Sleep Characteristics, Assessed in the At-home PSG

    Change from baseline to post-treatment (Week 2; Week 10)

  • Daily Sleep Characteristics

    From baseline to end of treatment/waitlist period (Weeks 1 to 10)

  • Daily PTSD Symptom Severity

    From baseline to end of treatment/waitlist period (Weeks 1 to 10)

  • PTSD Symptoms (PCL-5)

    Change from baseline to end of treatment and follow-up (Week 2; 10; 18)

  • Insomnia Symptoms (ISI)

    Change from baseline to end of treatment and follow-up (Week 2; Week 10; Week 18)

  • +3 more secondary outcomes

Other Outcomes (12)

  • Experiential Avoidance (BEAQ)

    Change from baseline to post-treatment (Week 2; Week 10)

  • Nightmare Disorder Symptom Severity (NDI)

    Change from baseline to post-treatment (Week 2; Week 10)

  • Sleep Quality (PSQI)

    Change from baseline to post-treatment (Week 2; Week 10)

  • +9 more other outcomes

Study Arms (3)

Yoga nidra (30 minutes each day)

EXPERIMENTAL

Participants will listen to \~30-minute yoga nidra meditation recordings every day for 8 weeks.

Behavioral: Yoga nidra (full)

Yoga nidra (one 30-minute session/week, six 10-minute sessions/week)

EXPERIMENTAL

For 8 weeks, participants will be asked to listen to one \~30-minute yoga nidra meditation recording per week and six \~10-minute meditation recordings per week.

Behavioral: Yoga nidra (brief)

Waitlist Control

NO INTERVENTION

During the intervention period, waitlist participants will not receive an intervention. At the end of Week 10, participants will be randomly assigned to low-dose yoga nidra or high-dose yoga nidra intervention for following the 8-week period.

Interventions

The intervention consists of remotely delivered audio recordings (\~30 minute length) of iRest yoga nidra meditation instructions that participants will be asked to listen to daily for 8 weeks, for a total listening time of about 3.5 hours each week. The yoga nidra practices will be in the tradition of iRest. They will include the following sections: intention setting, articulating a heartfelt desire, inner resource, body sensing, breath sensing, emotion and cognition sensing and opposites, welcoming joy, witnessing awareness, and integration. Each week includes an additional brief (\~2-5 minute) introduction to one of the iRest yoga nidra sections. Participants will be asked to lie on a lightly cushioned surface when listening to the practices. Participants are informed that they may opt to listen to the recordings more often but are instructed to listen to the recordings at least once per day.

Also known as: iRest
Yoga nidra (30 minutes each day)

The intervention will consist of remotely delivered audio recordings of yoga nidra meditation instructions. Participants will be asked to listen to one \~30-minute practice and six \~10-minute practices per week (total listening time of \~1.5 hours each week) for 8 weeks. The yoga nidra practices will be in the tradition of iRest. They will include the following sections: intention setting, articulating a heartfelt desire, inner resource, body sensing, breath sensing, emotion and cognition sensing and opposites, welcoming joy, witnessing awareness, and integration. Each week includes an additional brief (2-5 minute) introduction to one of the iRest yoga nidra sections. Participants will be asked to lie on a lightly cushioned surface when listening to the practices. Participants are informed that they may opt to listen to the recordings more than once a day but are instructed to listen to the 30-minute recording once per week and the 10-minute meditations the other 6 days of the week.

Also known as: iRest
Yoga nidra (one 30-minute session/week, six 10-minute sessions/week)

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Endorses experiencing at least one lifetime very stressful or traumatic event that still causes distress
  • Score of 13 or higher on the 8-item PCL-5
  • Scoring 15 or higher on the Insomnia Severity Index, indicating the presence of moderate to severe insomnia
  • Being able and willing to listen to online yoga nidra audio recordings that may each be up to 35 minutes long daily for 8 weeks
  • Being willing to monitor sleep and PTSD symptoms for 10 weeks
  • Normal or corrected to normal hearing and vision
  • Fluent in English
  • Reliable daily access to the internet
  • Between the ages of 18 and 35
  • Reliable daily access to the internet
  • Willing to refrain from ingesting caffeine, alcohol, and recreational drugs the day of the sleep studies

You may not qualify if:

  • History of schizophrenia, psychotic disorder, or bipolar disorder
  • Currently receiving or seeking treatment for alcoholism or a substance abuse disorder
  • Currently taking part in another study intended to treat poor sleep or posttraumatic stress symptoms
  • Current endorsement of suicidality (score of 2 or higher on Item 9 of the BDI-II)
  • Self-harmed or attempted suicide within the past 6 months
  • Currently receiving treatment for any mental health disorder or sleep disorder
  • Current diagnosis of any sleep disorder, excluding insomnia or nightmare disorder
  • Currently taking benzodiazepines, nonbenzodiazepine receptor agonists, orexin agonists or antagonists, antiseizure medication, or any medications for sleep or psychiatric indications
  • Score of 5 or higher on STOP-BANG Questionnaire (indicating likelihood of moderate to severe obstructive sleep apnea)
  • Previous adverse experience with meditation
  • Current regular meditative practice (meditating once or more per month)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College London

London, United Kingdom

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSleep Initiation and Maintenance DisordersStress, PsychologicalPsychological Trauma

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBehavioral SymptomsBehavior

Study Officials

  • Sunjeev Kamboj, PhD

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be blinded to the presence of two different yoga nidra groups (high-dose and low-dose) during their participation in the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-arm parallel assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2025

First Posted

March 21, 2025

Study Start

March 3, 2025

Primary Completion

March 17, 2026

Study Completion

March 17, 2026

Last Updated

May 4, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified demographic, questionnaire, and physiological participant data will be shared.

Shared Documents
STUDY PROTOCOL
Time Frame
Anticipated to begin within 18 months of completion of data collection
Access Criteria
Data will be made available through controlled access with the National Sleep Research Repository (NSRR), which aims to make data available indefinitely.

Locations